The tachykinins substance P and hemokinin-1 favor the generation of human memory Th17 Cells by Inducing IL-1β, IL-23, and TNF-like 1A expression by monocytes

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 4175-4182

  Cunin, Pierre ^a,b   Caillon, Antoine ^a,b   Corvaisier, Murielle ^a,b   Garo, Erwan ^a,b,c   Scotet, Mari ^a,b   Blanchard, Simon ^a,b,c   Delneste, Yves ^a,b,c   Jeannin, Pascale ^a,b,c  

^a Team 12   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HEMOKININ 1; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; NEUROKININ 1 RECEPTOR; NEUROKININ A; NEUROKININ B; SUBSTANCE P; TACHYKININ; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR LIKE 1A; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; MEMORY T LYMPHOCYTE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH17 CELL; UPREGULATION;

EID: 79955046707     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002535     Document Type: Article

References (56)

1. Sternberg, E. M. 2006. Neural regulation of innate immunity: A coordinated nonspecific host response to pathogens. Nat. Rev. Immunol. 6: 318-328.
2. Brogden, K. A., J. M. Guthmiller, M. Salzet, and M. Zasloff. 2005. The nervous system and innate immunity: The neuropeptide connection. Nat. Immunol. 6: 558-564. (Pubitemid 41710725)
3. Severini, C., G. Improta, G. Falconieri-Erspamer, S. Salvadori, and V. Erspamer. 2002. The tachykinin peptide family. Pharmacol. Rev. 54: 285-322. (Pubitemid 34575718)
4. Otsuka, M., and K. Yoshioka. 1993. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 73: 229-308. (Pubitemid 23119035)
5. Pernow, B. 1983. Substance P. Pharmacol. Rev. 35: 85-141.
6. Koon, H. W., and C. Pothoulakis. 2006. Immunomodulatory properties of substance P: The gastrointestinal system as a model. Ann. N. Y. Acad. Sci. 1088: 23-40. (Pubitemid 47092045)
7. Zhang, Y., A. Berger, C. D. Milne, and C. J. Paige. 2006. Tachykinins in the immune system. Curr. Drug Targets 7: 1011-1020. (Pubitemid 44227584)
8. Zhang, Y., L. Lu, C. Furlonger, G. E. Wu, and C. J. Paige. 2000. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat. Immunol. 1: 392-397.
9. O'Connor, T. M., J. O'Connell, D. I. O'Brien, T. Goode, C. P. Bredin, and F. Shanahan. 2004. The role of substance P in inflammatory disease. J. Cell. Physiol. 201: 167-180. (Pubitemid 39305095)
10. Metwali, A., A. M. Blum, D. E. Elliott, T. Setiawan, and J. V. Weinstock. 2004. Cutting edge: Hemokinin has substance P-like function and expression in inflammation. J. Immunol. 172: 6528-6532. (Pubitemid 38669085)
11. Lotz, M., J. H. Vaughan, and D. A. Carson. 1988. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241: 1218-1221.
12. Lang, K., T. L. Drell, B. Niggemann, K. S. Zänker, and F. Entschladen. 2003. Neurotransmitters regulate the migration and cytotoxicity in natural killer cells. Immunol. Lett. 90: 165-172. (Pubitemid 37548472)
13. Croitoru, K., P. B. Ernst, J. Bienenstock, I. Padol, and A. M. Stanisz. 1990. Selective modulation of the natural killer activity of murine intestinal intraepithelial leucocytes by the neuropeptide substance P. Immunology 71: 196-201. (Pubitemid 20341217)
14. Calvo, C. F., G. Chavanel, and A. Senik. 1992. Substance P enhances IL-2 expression in activated human T cells. J. Immunol. 148: 3498-3504.
15. Zhang, Y., and C. J. Paige. 2003. T-cell developmental blockage by tachykinin antagonists and the role of hemokinin 1 in T lymphopoiesis. Blood 102: 2165-2172. (Pubitemid 37122394)
16. Wang, W., Q. Li, J. Zhang, H. Wu, Y. Yin, Q. Ge, and Y. Zhang. 2010. Hemokinin-1 activates the MAPK pathway and enhances B cell proliferation and antibody production. J. Immunol. 184: 3590-3597.
17. Mathers, A. R., O. A. Tckacheva, B. M. Janelsins, W. J. Shufesky, A. E. Morelli, and A. T. Larregina. 2007. In vivo signaling through the neurokinin 1 receptor favors transgene expression by Langerhans cells and promotes the generation of Th1-and Tc1-biased immune responses. J. Immunol. 178: 7006-7017. (Pubitemid 46847427)
18. Janelsins, B. M., A. R. Mathers, O. A. Tkacheva, G. Erdos, W. J. Shufesky, A. E. Morelli, and A. T. Larregina. 2009. Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity. Blood 113: 3017-3026.
19. Lambrecht, B. N., P. R. Germonpré, E. G. Everaert, I. Carro-Muino, M. De Veerman, C. de Felipe, S. P. Hunt, K. Thielemans, G. F. Joos, and R. A. Pauwels. 1999. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur. J. Immunol. 29: 3815-3825.
20. Zhou, L., M. M. Chong, and D. R. Littman. 2009. Plasticity of CD4+ T cell lineage differentiation. Immunity 30: 646-655.
21. Gonzalez-Rey, E., A. Chorny, and M. Delgado. 2007. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat. Rev. Immunol. 7: 52-63. (Pubitemid 46020827)
22. Aliberti, J., J. P. Viola, A. Vieira-de-Abreu, P. T. Bozza, A. Sher, and J. Scharfstein. 2003. Cutting edge: Bradykinin induces IL-12 production by dendritic cells: A danger signal that drives Th1 polarization. J. Immunol. 170: 5349-5353. (Pubitemid 36617818)
23. Akbar, A., Y. Yiangou, P. Facer, J. R. Walters, P. Anand, and S. Ghosh. 2008. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 57: 923-929. (Pubitemid 351919527)
24. Menkes, C. J., M. Renoux, S. Laoussadi, A. Mauborgne, J. Bruxelle, and F. Cesselin. 1993. Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. J. Rheumatol. 20: 714-717. (Pubitemid 23138865)
25. Goode, T., J. O'Connell, P. Anton, H. Wong, J. Reeve, G. C. O'Sullivan, J. K. Collins, and F. Shanahan. 2000. Neurokinin-1 receptor expression in inflammatory bowel disease: Molecular quantitation and localisation. Gut 47: 387-396.
26. Annunziato, F., L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Filì, S. Ferri, F. Frosali, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204: 1849-1861. (Pubitemid 47240944)
27. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1b and 6 but not transforming growth factor-b are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942-949. (Pubitemid 47300008)
28. Evans, H. G., T. Suddason, I. Jackson, L. S. Taams, and G. M. Lord. 2007. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc. Natl. Acad. Sci. USA 104: 17034-17039. (Pubitemid 350210986)
29. van Beelen, A. J., Z. Zelinkova, E. W. Taanman-Kueter, F. J. Muller, D. W. Hommes, S. A. Zaat, M. L. Kapsenberg, and E. C. de Jong. 2007. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27: 660-669. (Pubitemid 47615504)
30. Hurme, M. 1987. Membrane-associated interleukin 1 is required for the activation of T cells in the anti-CD3 antibody-induced T cell response. J. Immunol. 139: 1168-1172. (Pubitemid 17134181)
31. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(2DDC(T)) method. Methods 25: 402-408. (Pubitemid 34164012)
32. Cascieri, M. A., E. Ber, T. M. Fong, S. Sadowski, A. Bansal, C. Swain, E. Seward, B. Frances, D. Burns, and C. D. Strader. 1992. Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor. Mol. Pharmacol. 42: 458-463. (Pubitemid 23024665)
33. Volpe, E., N. Servant, R. Zollinger, S. I. Bogiatzi, P. Hupé, E. Barillot, and V. Soumelis. 2008. A critical function for transforming growth factor-b, interleukin 23 and proinflammatory cytokines in driving and modulating human T (H)-17 responses. Nat. Immunol. 9: 650-657. (Pubitemid 351712635)
34. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 cells. Annu. Rev. Immunol. 27: 485-517.
35. Seliger, B., F. M. Marincola, S. Ferrone, and H. Abken. 2008. The complex role of B7 molecules in tumor immunology. Trends Mol. Med. 14: 550-559.
36. Croft, M. 2009. The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9: 271-285.
37. Yang, L., D. E. Anderson, C. Baecher-Allan, W. D. Hastings, E. Bettelli, M. Oukka, V. K. Kuchroo, and D. A. Hafler. 2008. IL-21 and TGF-b are required for differentiation of human T(H)17 cells. Nature 454: 350-352.
38. Screaton, G. R., X. N. Xu, A. L. Olsen, A. E. Cowper, R. Tan, A. J. McMichael, and J. I. Bell. 1997. LARD: A new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 94: 4615-4619. (Pubitemid 27194291)
39. Bayry, J. Immunology: TL1A in the inflammatory network in autoimmune diseases. Nat. Rev. Rheumatol. 6: 67-68.
40. Kamada, N., T. Hisamatsu, H. Honda, T. Kobayashi, H. Chinen, T. Takayama, M. T. Kitazume, S. Okamoto, K. Koganei, A. Sugita, T. Kanai, and T. Hibi. 2010. TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease. Inflamm. Bowel Dis. 16: 568-575.
41. Takedatsu, H., K. S. Michelsen, B. Wei, C. J. Landers, L. S. Thomas, D. Dhall, J. Braun, and S. R. Targan. 2008. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 135: 552-567.
42. Pappu, B. P., A. Borodovsky, T. S. Zheng, X. Yang, P. Wu, X. Dong, S. Weng, B. Browning, M. L. Scott, L. Ma, et al. 2008. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J. Exp. Med. 205: 1049-1062. (Pubitemid 351679681)
43. Migone, T. S., J. Zhang, X. Luo, L. Zhuang, C. Chen, B. Hu, J. S.Hong, J.W. Perry, S. F. Chen, J. X. Zhou, et al. 2002. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16: 479-492. (Pubitemid 34260924)
44. Biener-Ramanujan, E., R. Gonsky, B. Ko, and S. R. Targan. 2010. Functional signaling of membrane-bound TL1A induces IFN-g expression. FEBS Lett. 584: 2376-2380.
45. Wilson, N. J., K. Boniface, J. R. Chan, B. S. McKenzie, W. M. Blumenschein, J. D. Mattson, B. Basham, K. Smith, T. Chen, F. Morel, et al. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8: 950-957. (Pubitemid 47300009)
46. Goode, T., J. O'Connell, W. Z. Ho, G. C. O'Sullivan, J. K. Collins, S. D. Douglas, and F. Shanahan. 2000. Differential expression of neurokinin-1 receptor by human mucosal and peripheral lymphoid cells. Clin. Diagn. Lab. Immunol. 7: 371-376. (Pubitemid 30263027)
47. Lai, J. P., W. Z. Ho, L. E. Kilpatrick, X. Wang, F. Tuluc, H. M. Korchak, and S. D. Douglas. 2006. Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation. Proc. Natl. Acad. Sci. USA 103: 7771-7776.
48. Fong, T. M., S. A. Anderson, H. Yu, R. R. Huang, and C. D. Strader. 1992. Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol. Pharmacol. 41: 24-30.
49. Bost, K. L. 2004. Tachykinin-mediated modulation of the immune response. Front. Biosci. 9: 3331-3332.
50. Scicchitano, R., J. Biennenstock, and A. M. Stanisz. 1988. In vivo immunomodulation by the neuropeptide substance P. Immunology 63: 733-735.
51. Remröd, C., S. Lonne-Rahm, and K. Nordlind. 2007. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus. Arch. Dermatol. Res. 299: 85-91. (Pubitemid 46669413)
52. Evans, H. G., N. J. Gullick, S. Kelly, C. Pitzalis, G. M. Lord, B. W. Kirkham, and L. S. Taams. 2009. In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses. Proc. Natl. Acad. Sci. USA 106: 6232-6237.
53. Bradshaw, E. M., K. Raddassi, W. Elyaman, T. Orban, P. A. Gottlieb, S. C. Kent, and D. A. Hafler. 2009. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J. Immunol. 183: 4432-4439.
54. Nessler, S., C. Stadelmann, A. Bittner, K. Schlegel, F. Gronen, W. Brueck, B. Hemmer, and N. Sommer. 2006. Suppression of autoimmune encephalomyelitis by a neurokinin-1 receptor antagonist-a putative role for substance P in CNS inflammation. J. Neuroimmunol. 179: 1-8. (Pubitemid 44441598)
55. Di Sebastiano, P., L. Grossi, F. F. Di Mola, D. Angelucci, H. Friess, L. Marzio, P. Innocenti, and M. W. Büchler. 1999. SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis. Dig. Dis. Sci. 44: 439-444. (Pubitemid 29093573)
56. Sturiale, S., G. Barbara, B. Qiu, M. Figini, P. Geppetti, N. Gerard, C. Gerard, E. F. Grady, N. W. Bunnett, and S. M. Collins. 1999. Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc. Natl. Acad. Sci. USA 96: 11653-11658. (Pubitemid 29487436)